Annual Working Capital
$2.26 M
+$491.90 K+27.81%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual working capital is $2.26 million, with the most recent change of +$491.90 thousand (+27.81%) on December 31, 2023.
- During the last 3 years, COEP annual working capital has risen by +$7.32 million (+144.73%).
- COEP annual working capital is now at all-time high.
Performance
COEP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$2.08 M
-$440.80 K-26.96%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly working capital is -$2.08 million, with the most recent change of -$440.80 thousand (-26.96%) on September 1, 2024.
- Over the past year, COEP quarterly working capital has dropped by -$836.60 thousand (-67.52%).
- COEP quarterly working capital is now -167.74% below its all-time high of $3.06 million, reached on September 30, 2022.
Performance
COEP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
COEP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.8% | -67.5% |
| 3 y3 years | +144.7% | -10.5% |
| 5 y5 years | +144.7% | -10.5% |
COEP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +486.2% | -167.7% | at low |
| 5 y | 5-year | at high | +144.7% | -167.7% | at low |
| alltime | all time | at high | +144.7% | -167.7% | at low |
Coeptis Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$2.08 M(+27.0%) |
| Jun 2024 | - | -$1.63 M(-163.4%) |
| Mar 2024 | - | $2.58 M(-308.1%) |
| Dec 2023 | $2.26 M(+27.8%) | -$1.24 M(-149.5%) |
| Sep 2023 | - | $2.50 M(+95.1%) |
| Jun 2023 | - | $1.28 M(+332.3%) |
| Mar 2023 | - | $296.90 K(-83.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.77 M(-402.2%) | $1.77 M(-42.3%) |
| Sep 2022 | - | $3.06 M(-263.2%) |
| Jun 2022 | - | -$1.88 M(+419.6%) |
| Mar 2022 | - | -$361.40 K(-38.3%) |
| Dec 2021 | -$585.40 K(-88.4%) | - |
| Dec 2021 | - | -$585.30 K |
| Dec 2020 | -$5.05 M | - |
FAQ
- What is Coeptis Therapeutics annual working capital?
- What is the all time high annual working capital for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual working capital year-on-year change?
- What is Coeptis Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly working capital year-on-year change?
What is Coeptis Therapeutics annual working capital?
The current annual working capital of COEP is $2.26 M
What is the all time high annual working capital for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual working capital is $2.26 M
What is Coeptis Therapeutics annual working capital year-on-year change?
Over the past year, COEP annual working capital has changed by +$491.90 K (+27.81%)
What is Coeptis Therapeutics quarterly working capital?
The current quarterly working capital of COEP is -$2.08 M
What is the all time high quarterly working capital for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly working capital is $3.06 M
What is Coeptis Therapeutics quarterly working capital year-on-year change?
Over the past year, COEP quarterly working capital has changed by -$836.60 K (-67.52%)